J&J doubles down on neurological drugs with $14.6 bln Intra-Cellular deal – Reuters

Business News

  1. J&J doubles down on neurological drugs with $14.6 bln Intra-Cellular deal  Reuters
  2. J&J to Acquire Intra-Cellular for About $14.6 Billion  Bloomberg
  3. J&J to buy psychiatric drug developer Intra-Cellular for $14.6B  BioPharma Dive
  4. Johnson & Johnson in $14.6 Billion Deal to Buy Biotech Intra-Cellular  Barron’s
  5. JPM25, Day 1: Pfizer CEO discusses plan to overcome $17B ‘LOE wave’  FiercePharma

Source: Business News

/by